- Home
- RVPH vs ZCMD Comparison
RVPH vs ZCMD Comparison
Compare RVPH & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- ZCMD
- Stock Information
- Founded
- RVPH 2006
- ZCMD 2012
- Country
- RVPH United States
- ZCMD China
- Employees
- RVPH N/A
- ZCMD N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- ZCMD Other Consumer Services
- Sector
- RVPH Health Care
- ZCMD Real Estate
- Exchange
- RVPH Nasdaq
- ZCMD Nasdaq
- Market Cap
- RVPH 32.8M
- ZCMD 29.0M
- IPO Year
- RVPH N/A
- ZCMD 2020
- Fundamental
- Price
- RVPH $0.40
- ZCMD $1.16
- Analyst Decision
- RVPH Strong Buy
- ZCMD
- Analyst Count
- RVPH 5
- ZCMD 0
- Target Price
- RVPH $9.00
- ZCMD N/A
- AVG Volume (30 Days)
- RVPH 3.4M
- ZCMD 506.1K
- Earning Date
- RVPH 08-13-2025
- ZCMD 01-01-0001
- Dividend Yield
- RVPH N/A
- ZCMD N/A
- EPS Growth
- RVPH N/A
- ZCMD N/A
- EPS
- RVPH N/A
- ZCMD N/A
- Revenue
- RVPH N/A
- ZCMD $15,864,773.00
- Revenue This Year
- RVPH N/A
- ZCMD N/A
- Revenue Next Year
- RVPH N/A
- ZCMD N/A
- P/E Ratio
- RVPH N/A
- ZCMD N/A
- Revenue Growth
- RVPH N/A
- ZCMD N/A
- 52 Week Low
- RVPH $0.30
- ZCMD $0.95
- 52 Week High
- RVPH $4.28
- ZCMD $2.97
- Technical
- Relative Strength Index (RSI)
- RVPH 33.44
- ZCMD 46.90
- Support Level
- RVPH $0.35
- ZCMD $1.12
- Resistance Level
- RVPH $0.83
- ZCMD $1.24
- Average True Range (ATR)
- RVPH 0.06
- ZCMD 0.13
- MACD
- RVPH -0.01
- ZCMD -0.01
- Stochastic Oscillator
- RVPH 17.36
- ZCMD 16.03
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.